Carter Bankshares 10-Q Details Q3 EPS of $0.35 and $12.1M Net Charge-Offs
CARE sits 70% above its 52-week low of $16.86 on light trading volume (0.2× avg).
Summary
Carter Bankshares' 10-Q fills in the detail behind the already-reported $0.35 Q3 EPS: a $10.5M credit provision driven by $12.1M of net charge-offs, against a net interest margin that widened to 3.51% from 2.86% a year ago.
Key Events · Earnings and Guidance · CARE
-
Q3 EPS of $0.35 Confirmed in 10-Q
Net income of $7.8 million, or $0.35 diluted EPS, for the three months ended September 30, 2026; nine-month net income was $122.4 million, or $5.53 per share, inflated by the $65.0 million loan-sale gain and $35.9 million insurance gain.
-
Credit Provision Jumps to $10.5M
The Q3 provision for credit losses was $10.5 million versus $2.9 million a year earlier, driven by $12.1 million of net charge-offs — an $8.0 million C&I charge-off following a voluntary Chapter 11 filing and a $4.0 million CRE charge-off.
-
Margin Widens to 3.51%
Net interest income rose 22.3% to $41.2 million and net interest margin expanded to 3.51% from 2.86%, helped by the securities portfolio repositioning and lower funding costs.
-
Nonperforming Loans Down to $27.9M
Nonperforming loans fell to $27.9 million, or 0.74% of portfolio loans, from $244.0 million, or 6.29%, after the first-quarter 2026 Loan Sale Transaction; the allowance for credit losses is now 1.42% of loans versus 1.84%.
Analysis · CARE · Finance
The headline Q3 numbers were already out on October 29, so the new information here is the credit detail behind them. A $10.5M quarterly provision and $12.1M of net charge-offs — including an $8.0M C&I charge-off after a borrower's voluntary Chapter 11 filing and a $4.0M CRE charge-off — show that even after the Justice loan sale cleaned up the balance sheet, individual credits can still bite. Offsetting that, the core bank is earning far more than a year ago: net interest margin of 3.51% versus 2.86% and net interest income up 22.3% to $41.2M. Nonperforming loans are down to $27.9M, or 0.74% of loans, from $244.0M, and capital is strong with a 14.24% CET1 ratio. The nine-month $5.53 EPS is flattered by the $65.0M loan-sale gain and $35.9M insurance gain, so the $0.35 quarterly run rate is the number that matters for the go-forward earnings base.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CARE was trading at $28.69 on NASDAQ in the Finance sector, with a market capitalization of approximately $633.8M. The 52-week trading range was $16.86 to $36.06. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.